ATNM
Price
$1.73
Change
-$0.05 (-2.81%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
55.53M
83 days until earnings call
OBIO
Price
$2.75
Change
+$0.03 (+1.10%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
147.3M
Interact to see
Advertisement

ATNM vs OBIO

Header iconATNM vs OBIO Comparison
Open Charts ATNM vs OBIOBanner chart's image
Actinium Pharmaceuticals
Price$1.73
Change-$0.05 (-2.81%)
Volume$300
Capitalization55.53M
Orchestra BioMed Holdings
Price$2.75
Change+$0.03 (+1.10%)
Volume$891
Capitalization147.3M
ATNM vs OBIO Comparison Chart in %
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. OBIO commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and OBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (ATNM: $1.78 vs. OBIO: $2.73)
Brand notoriety: ATNM and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 49% vs. OBIO: 34%
Market capitalization -- ATNM: $55.53M vs. OBIO: $147.3M
ATNM [@Biotechnology] is valued at $55.53M. OBIO’s [@Biotechnology] market capitalization is $147.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATNM is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while OBIO’s TA Score has 4 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 3 bearish.
  • OBIO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATNM is a better buy in the short-term than OBIO.

Price Growth

ATNM (@Biotechnology) experienced а +2.30% price change this week, while OBIO (@Biotechnology) price change was +7.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

ATNM is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OBIO($147M) has a higher market cap than ATNM($55.5M). ATNM YTD gains are higher at: 41.270 vs. OBIO (-31.750). ATNM has higher annual earnings (EBITDA): -43.43M vs. OBIO (-70.94M). ATNM has more cash in the bank: 59.9M vs. OBIO (33.9M). ATNM has less debt than OBIO: ATNM (1.29M) vs OBIO (16.4M). OBIO has higher revenues than ATNM: OBIO (2.94M) vs ATNM (0).
ATNMOBIOATNM / OBIO
Capitalization55.5M147M38%
EBITDA-43.43M-70.94M61%
Gain YTD41.270-31.750-130%
P/E RatioN/AN/A-
Revenue02.94M-
Total Cash59.9M33.9M177%
Total Debt1.29M16.4M8%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMOBIO
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
63%
Momentum
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
50%
MACD
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 5 days ago
41%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 5 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
63%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 8 days ago
63%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
60%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADBKF26.50N/A
N/A
ADDIKO BK AG
CEFC11.73N/A
N/A
Commercial National Financial Corp (MI)
MDTC0.04N/A
N/A
Media Technologies Inc.
SPASF2.50N/A
N/A
SATS Ltd.
AMCCF8.65N/A
N/A
Amcor plc

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with IPSC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+2.30%
IPSC - ATNM
48%
Loosely correlated
-1.68%
CRBU - ATNM
45%
Loosely correlated
-3.61%
RXRX - ATNM
43%
Loosely correlated
-3.39%
ADVM - ATNM
42%
Loosely correlated
+1.65%
PRME - ATNM
41%
Loosely correlated
-5.81%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with XBIT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then XBIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
+0.74%
XBIT - OBIO
41%
Loosely correlated
-6.78%
OCUL - OBIO
37%
Loosely correlated
-2.48%
BEAM - OBIO
37%
Loosely correlated
-2.91%
ITOS - OBIO
37%
Loosely correlated
N/A
ATNM - OBIO
37%
Loosely correlated
+2.30%
More